On the contrary, body weight loss and increased energy expenditure prevailed in transgenic mice expressing human FGF-19 and these mice furthermore presented a resistance to obesity and insulin desensitization [58]. The gene discussed is FGF19; the disease is obesity due to melanocortin 4 receptor deficiency.